Australian Clinical Labs Ltd (AU:ACL) has released an update.
JPMorgan Chase & Co. and its affiliates have reported a decrease in their voting power in Australian Clinical Labs Ltd, from 10.24% to 6.55%. The change occurred on September 17, 2024, involving various transactions including securities lending and proprietary trading. This shift in shareholding dynamics could interest investors monitoring the company’s stock ownership.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
